fda tirzepatide Wins Approval for Weight Loss FDA Approves Zepbound for Moderate-to-Severe

Rapid weight loss has many possible outcomes

Ozempic and Mounjaro are approved for the treatment of Type 2 diabetes, while Wegovy and Zepbound are approved for weight management in adults with obesity or who are overweight

Compensating for Supply Issues Due to increasing demand for GLP-1 drugs, there have been occasional shortages in the supply of medications like Ozempic and Wegovy

What to do if a pen overheats or freezes

Honest contraindication review: Active or recent malignancy, pregnancy, breastfeeding, uncontrolled diabetes, and severe pituitary disease are real contraindications

Oxidative Stress in Type 2 Diabetes Chronic hyperglycemia drives mitochondrial superoxide production, which depletes intracellular glutathione and raises systemic markers of oxidative damage